Skip to content

Impact of a Program of Non-pharmacological Intervention in Patients With Type 2 Diabetes Mellitus

Impact of a Program of Non-pharmacological Intervention in Patients With Type 2 Diabetes Mellitus With Poor Control of Their Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02456064
Enrollment
25
Registered
2015-05-28
Start date
2015-05-31
Completion date
2016-01-31
Last updated
2017-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Brief summary

The purpose of this study is to determine whether a non-drug intensive program can help improve control of type 2 diabetes mellitus.

Detailed description

This study is based on the creation of two groups of patients with type 2 diabetes mellitus over a period of six months . In one of the groups an intensive program be developed through : group medical consultations , workshops , informative talks, expert patient telephone inquiries .. etc. Meanwhile , the control group that will be followed in the consultations as usual. We will make a determination of HbA1c at 3 months and 6 months later to assess whether there are significant differences between the two groups .

Interventions

BEHAVIORALLifestyle counseling

* Group medical visits * Telephone medical consultations * Expert patient * Training workshops

Sponsors

Equipo Multidisciplinar Sanitario CS Foietes
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with type 2 diabetes mellitus with poor control of their disease. * No changes have been made in pharmacological previous 3 months.

Exclusion criteria

* Changes in their drug treatment in the past 3 months.

Design outcomes

Primary

MeasureTime frame
HbA1c6 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026